Calidi Biotherapeutics Inc (CLDI)

Currency in USD
0.2260
+0.0060(+2.73%)
Closed·
0.2267+0.0007(+0.31%)
·
Unusual trading volume
CLDI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.21120.2292
52 wk Range
0.208819.2000
Key Statistics
Prev. Close
0.22
Open
0.2239
Day's Range
0.2112-0.2292
52 wk Range
0.2088-19.2
Volume
2.93M
Average Volume (3m)
865.21K
1-Year Change
-96.1008%
Book Value / Share
0.51
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CLDI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
120.0048
Upside
+52,999.47%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Calidi Biotherapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcinoma, and soft tissue sarcoma, which is in pre-clinical studies; CLD-301 for multiple indications, which is in preclinical studies; and CLD-400 for certain lung cancer and metastatic solid tumors. The company also offers oncolytic virus platforms, such as NeuroNova, SuperNova, and RTNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.

Compare CLDI to Peers and Sector

Metrics to compare
CLDI
Peers
Sector
Relationship
P/E Ratio
−0.1x−2.6x−0.4x
PEG Ratio
0.00−0.240.00
Price/Book
0.7x2.6x2.6x
Price / LTM Sales
-101.8x3.2x
Upside (Analyst Target)
-187.6%46.2%
Fair Value Upside
Unlock26.9%7.2%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 120.0048
(+52,999.47% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
27-03-2026
EPS / Forecast
-0.57 / -0.22
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CLDI Income Statement

FAQ

What Is the Calidi Biotherapeutics (CLDI) Share Price Today?

The Calidi Biotherapeutics share price today is 0.2260 USD.

What is the current Calidi Biotherapeutics (CLDI) share price and day range?

As of 26-04-2026, the Calidi Biotherapeutics share price is 0.2260 USD, with a previous close of 0.2200 USD. The share price has ranged from 0.2112 to 0.2292 USD today, while the 52-week range spans from 0.2088 to 19.2000 USD.

What Is the Calidi Biotherapeutics Market Cap?

As of today, Calidi Biotherapeutics market cap is 2.5000M.

What Is the Calidi Biotherapeutics (CLDI) Share Price Target?

The average 12-month share price target for Calidi Biotherapeutics is 120.0048 USD, with a high estimate of 120.0048 USD and a low estimate of 120.0048 USD. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +52,999.47% Upside potential.

What Is Calidi Biotherapeutics's Earnings Per Share (TTM)?

The Calidi Biotherapeutics EPS (TTM) is -5.9458.

From a Technical Analysis Perspective, Is CLDI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does Calidi Biotherapeutics Trade On?

Calidi Biotherapeutics is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Calidi Biotherapeutics?

The stock symbol for Calidi Biotherapeutics is "CLDI."

How Many Times Has Calidi Biotherapeutics Stock Split?

Calidi Biotherapeutics has split 2 times.

How Many Employees Does Calidi Biotherapeutics Have?

Calidi Biotherapeutics has 29 employees.

What Is the CLDI Premarket Price?

CLDI's last pre-market stock price is 0.2210 USD. The pre-market share volume is 2,23,990.0000, and the stock has changed by 0.0010 USD, or 0.4500%.

What Is the CLDI After Hours Price?

CLDI's last after hours stock price is 0.2267 USD, the stock has changed by 0.0007 USD, or 0.3100%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.